Changes in BMI in hospitalized patients during treatment with antipsychotics, depending on gender and other factors

International Journal of Psychiatry in Clinical Practice
Lenka SušilováJan Šimůnek

Abstract

To investigate the differences in body mass index (BMI) changes between men and women during hospitalization. The retrospective study monitored demographic and clinical data of 462 schizophrenic patients hospitalized 737 times between 2006 and 2011. BMI analysis was performed on patients on antipsychotic medication hospitalized longer than four days. Patients with an initial BMI < 25 gained more weight than patients with a BMI > 25 (3.94% vs. 0.23%, men 4.02% vs. 0.69%, women 3.79% vs. -0.52%, always p < 0.001). Greater BMI gains were reported during the first hospitalization than during subsequent ones (3.94% vs. 1.66%, men 3.97% vs. 1.98%, women 3.88% vs. 1.18%, always p < 0.001). The comparison between men and women showed a higher increase in BMI in men 2.36% vs. 1.54%, p = 0.022. Men also gained significantly more weight than women on polytherapy (+2.55% vs. +1.37%) and during subsequent hospitalizations (1.98% vs. 1.18%). For treatment with various atypical antipsychotics (AP), no significant differences were found in weight changes between men and women; during treatment using a combination of multi-receptor AP and metabolically neutral aripiprazole, a significant increase of BMI occurred in men, but not in women (p = 0....Continue Reading

References

Jan 17, 1997·Schizophrenia Research·R K SalokangasE Syvälahti
May 31, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·A S JacksonJ H Wilmore
May 20, 2003·Respirology : Official Journal of the Asian Pacific Society of Respirology·Judith Mackay, Amanda Amos
Aug 5, 2004·The Journal of Clinical Psychiatry·Mong-Liang LuWen-Ho Chang
Apr 27, 2005·International Journal of Obesity : Journal of the International Association for the Study of Obesity·C BergL Lissner
Jun 7, 2006·Psychiatric Services : a Journal of the American Psychiatric Association·Linda S GrossmanRobert Faull
Jun 21, 2006·Journal of Psychopharmacology·Gavin P ReynoldsShona L Kirk
Oct 31, 2006·Schizophrenia Research·Christoph U CorrellPeter Manu
Jun 27, 2007·The Journal of Clinical Psychiatry·Rohan GanguliJohn W Newcomer
Dec 27, 2008·Journal of Psychiatric Research·Stefan GebhardtFrank M Theisen
Aug 7, 2009·Psychological Medicine·I TarriconeD Berardi
Oct 29, 2009·JAMA : the Journal of the American Medical Association·Christoph U CorrellAnil K Malhotra
Dec 28, 2010·Trends in Molecular Medicine·Christoph U CorrellAnil K Malhotra
Oct 20, 2011·Nature Reviews. Endocrinology·Marc De HertChristoph U Correll
Nov 1, 2011·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·B XiJ Mi
Dec 14, 2011·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·J L Gutiérrez-FisacF Rodríguez-Artalejo
Aug 1, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·P LiN Liu
Apr 26, 2014·PloS One·Maarten BakMarjan Drukker
Aug 21, 2014·Current Psychiatry Reports·Tahireh A Shams, Daniel J Müller
Nov 18, 2014·Expert Opinion on Drug Safety·Richard MusilMichael Hamerle
May 29, 2015·Acta Psychiatrica Scandinavica·P ManuC U Correll
Jun 5, 2015·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Christoph U CorrellMarc De Hert
Jun 24, 2015·Endocrine, Metabolic & Immune Disorders Drug Targets·Hubertus HimmerichKenneth C Kirkby

❮ Previous
Next ❯

Citations

Sep 17, 2019·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Lucia Alonso-PedreroAmelia Marti
Jan 15, 2018·European Psychiatry : the Journal of the Association of European Psychiatrists·Christina EngelkeJoachim Cordes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.